HomeInsightsResults

Sun Pharma Advanced Research Company Ltd Quarterly Result

Sun Pharma Advanced Research Company Ltd Quarterly Result

stocks purchased

₹ 2.8 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

138.6 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 22, 2024

Image

Sun Pharma Advanced Research Company Ltd

NSE: SPARC

Net Profit

₹ -107.33

Last updated on: Nov 22, 2024

Key Highlights

  • The revenue of Sun Pharma Advanced Research Company Ltd for the Sep '24 is ₹ 12.9 crore as compare to the Jun '24 revenue of ₹ 18.37 crore. This represent the decline of -29.776815%.
  • The ebitda of Sun Pharma Advanced Research Company Ltd for the Sep '24 is ₹ -102 crore as compare to the Jun '24 ebitda of ₹ -91.8 crore. This represent the growth of 12.058824%.
  • The net profit of Sun Pharma Advanced Research Company Ltd for the Sep '24 is ₹ -107 crore as compare to the Jun '24 net profit of ₹ -95.9 crore. This represent the growth of 11.918665%.

Results Analysis

Market Price of Sun Pharma Advanced Research Company Ltd

1M

1Y

3Y

5Y

Monitoring Sun Pharma Advanced Research Company Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 2024204.4
21 Nov 2024190.4
19 Nov 2024196.1
18 Nov 2024194.4
14 Nov 2024197.2
13 Nov 2024198.45
12 Nov 2024206.3
11 Nov 2024206.7
08 Nov 2024206.25
07 Nov 2024212.1

Historical Revenue of Sun Pharma Advanced Research Company Ltd

No data available

* All values are in crore

Historical EBITDA of Sun Pharma Advanced Research Company Ltd

No data available

* All values are in crore

Historical Net Profit of Sun Pharma Advanced Research Company Ltd

No data available

* All values are in crore

Sun Pharma Advanced Research Company Ltd News Hub

News

Volumes jump at Sun Pharma Advanced Research Company Ltd counter

Raymond Ltd, Praj Industries Ltd, Adani Green Energy Ltd, Mangalore Refinery And Petrochem...

Read more

22 Nov 202414:30

News

SPARC drops as Q2 net loss widens to Rs 107 crore

Net sales declined 39.29% year on year (YoY) to 12.86 crore in the quarter ended 30 Septem...

Read more

04 Nov 202417:01

News

Sun Pharma Advanced Research Company to convene board meeting

Sun Pharma Advanced Research Company will hold a meeting of the Board of Directors of the ...

Read more

25 Oct 202416:11

News

Sun Pharma Advanced Research Company announces board meeting date

Sun Pharma Advanced Research Company will hold a meeting of the Board of Directors of the ...

Read more

30 Jul 202411:28

News

Sun Pharma Advanced Research Company to conduct AGM

Sun Pharma Advanced Research Company announced that the 19th Annual General Meeting (AGM) ...

Read more

09 Jul 202412:07

News

SPARC CFO Chetan Rajpara resigns

Rajpara stated that he wants to pursue his ambition and personal goals, which would involv...

Read more

06 Jun 202412:43

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQ's For Sun Pharma Advanced Research Company Ltd Quarterly Result

What is the EPS of Sun Pharma Advanced Research Company Ltd stock?

The Earnings Per Share (EPS) of Sun Pharma Advanced Research Company Ltd is 0.0. An EPS is the amount of net income attributed to each share of a common stock.

How is Sun Pharma Advanced Research Company Ltd EPS calculated?

The EPS of Sun Pharma Advanced Research Company Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Sun Pharma Advanced Research Company Ltd report its EPS?

Sun Pharma Advanced Research Company Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Sun Pharma Advanced Research Company Ltd EPS?

Factors that influence the EPS of Sun Pharma Advanced Research Company Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Sun Pharma Advanced Research Company Ltd EPS growth indicate future performance?

Yes, consistent growth in Sun Pharma Advanced Research Company Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*